Business Context and Reporting Period
Company: Amphenol Corporation (APH)
Filing Type: Form 8-K (Current Report)
Date of Report: January 28, 2026
Reporting Period: Quarter and fiscal year ended December 31, 2025
This filing serves as a notification that the Company issued a press release detailing its financial results for the fourth quarter and full year of 2025. The press release is attached as Exhibit 99.1 and incorporated by reference.
Key Financial Metrics
The provided text is a cover sheet and does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the referenced press release (Exhibit 99.1), which is not included in the input text.
Note: The filing text does not provide a clear value for any specific financial metric.
Material Changes
No specific material changes versus prior periods are detailed in this document. The filing indicates that results for the quarter and year ended December 31, 2025, have been released, but the comparative analysis is located in the attached press release.
Guidance, Outlook, and Risks
Forward-Looking Statements: The filing includes standard disclosures regarding forward-looking statements related to expected business and financial performance, earnings, revenues, growth, liquidity, and tax rates. These statements are subject to risks and uncertainties.
Risk Factors: The document directs investors to the "Risk Factors" section in the Company's Annual Report on Form 10-K for the year ended December 31, 2024, and other SEC filings for a detailed description of uncertainties that could cause actual results to differ materially from expectations.
Unusual Items: No unusual items are explicitly described in this text.
Investor Verification Checklist
- Review the attached Press Release (Exhibit 99.1) for specific Q4 and full-year 2025 revenue, earnings, and cash flow figures.
- Verify the Company's updated guidance for fiscal year 2026 within the press release.
- Consult the most recent Form 10-K (2024) for detailed risk factors referenced in this filing.
- Confirm the status of any acquisitions or strategic initiatives mentioned in the forward-looking statements.